Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis

Am J Kidney Dis. 2009 Apr;53(4):617-27. doi: 10.1053/j.ajkd.2008.08.033. Epub 2008 Nov 22.

Abstract

Background: Optimal hydration measures to prevent contrast-induced nephropathy are controversial.

Study design: We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings.

Setting & population: Adult patients undergoing contrast procedures.

Selection criteria for studies: Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy.

Intervention: Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine.

Outcomes: Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure.

Results: Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy.

Limitation: Publication bias and heterogeneity.

Conclusion: Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Contrast Media / adverse effects*
  • Humans
  • Infusions, Intravenous
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / prevention & control*
  • Randomized Controlled Trials as Topic
  • Sodium Bicarbonate / administration & dosage
  • Sodium Bicarbonate / therapeutic use*
  • Sodium Chloride / administration & dosage
  • Sodium Chloride / therapeutic use
  • Treatment Outcome

Substances

  • Contrast Media
  • Sodium Chloride
  • Sodium Bicarbonate